Literature DB >> 35505921

The Patient Perspective on Telemedicine.

Karen Hoyt1, Andrew Reynolds2.   

Abstract

Content available: Author Audio Recording.
© 2021 by the American Association for the Study of Liver Diseases.

Entities:  

Year:  2022        PMID： 35505921      PMCID： PMC9053679          DOI： 10.1002/cld.1188

Source DB:  PubMed          Journal:  Clin Liver Dis (Hoboken)        ISSN： 2046-2484


  7 in total

1.  A framework for patient-centered telemedicine: Application and lessons learned from vulnerable populations.

Authors:  Andrew H Talal; Elisavet M Sofikitou; Urmo Jaanimägi; Marija Zeremski; Jonathan N Tobin; Marianthi Markatou
Journal:  J Biomed Inform       Date:  2020-11-10       Impact factor: 6.317

Review 2.  Telehealth and patient satisfaction: a systematic review and narrative analysis.

Authors:  Clemens Scott Kruse; Nicole Krowski; Blanca Rodriguez; Lan Tran; Jackeline Vela; Matthew Brooks
Journal:  BMJ Open       Date:  2017-08-03       Impact factor: 2.692

3.  Patient Characteristics Associated With Choosing a Telemedicine Visit vs Office Visit With the Same Primary Care Clinicians.

Authors:  Mary E Reed; Jie Huang; Ilana Graetz; Catherine Lee; Emilie Muelly; Chris Kennedy; Eileen Kim
Journal:  JAMA Netw Open       Date:  2020-06-01

4.  Racial and Socioeconomic Disparities in Utilization of Telehealth in Patients with Liver Disease During COVID-19.

Authors:  Kara Wegermann; Julius M Wilder; Alice Parish; Donna Niedzwiecki; Ziad F Gellad; Andrew J Muir; Yuval A Patel
Journal:  Dig Dis Sci       Date:  2021-01-28       Impact factor: 3.487

Review 5.  Telemedicine and Telehepatology During the COVID-19 Pandemic.

Authors:  Oren K Fix; Marina Serper
Journal:  Clin Liver Dis (Hoboken)       Date:  2020-05-21

6.  Patient Satisfaction With Telemedicine During the COVID-19 Pandemic: Retrospective Cohort Study.

Authors:  Ashwin Ramaswamy; Miko Yu; Siri Drangsholt; Eric Ng; Patrick J Culligan; Peter N Schlegel; Jim C Hu
Journal:  J Med Internet Res       Date:  2020-09-09       Impact factor: 5.428
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.